Inducing autoimmune disease to treat cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 10, 1999, Pages 5340-5342

  Pardoll, D M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOPHENOL MONOOXYGENASE;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; GENETIC STABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYME DISEASE; NOTE; PRIORITY JOURNAL; TISSUE SPECIFICITY; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; AUTOIMMUNITY; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE;

EID: 0033545982     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.10.5340     Document Type: Note

References (31)